STC1 and ovarian carcinoma: Emerging evidences have demonstrated that STC1 is abnormally expressed in tumor tissues and is associated with tumor cell proliferation, migration, apoptosis and disease prognosis, such as non-small cell lung cancer, renal cell carcinoma, leukemia, lung adenocarcinoma, glioma, colon cancer, prostate cancer, ovarian cancer, etc.